父母人类白细胞抗原-C同种异型可预测辅助生殖治疗中的活产率及不良胎盘形成风险
前瞻性观察性队列研究纳入204例反复生殖失败女性,分析母体KIR基因与父源或卵母细胞供者HLA-C基因对妊娠结局的影响。发现KIR AA母亲双胚胎移植后流产率较高,活产率在卵母细胞捐赠双胚胎移植后显著降低;胎儿HLA-C2负荷增加与KIR AA女性活产率下降相关。
要点
- KIR AA母亲双胚胎移植后流产率:卵母细胞捐赠47.8%、体外受精37.5%。
- KIR AA患者卵母细胞捐赠双胚胎移植后活产率4.3%,低于KIR AB的26.3%和BB的46.7%。
- KIR AA女性中胎儿HLA-C2负荷增加与活产率显著降低相关。
核心结论
- 选择性单胚胎移植较双胚胎移植改善生殖结局。
- 胚胎HLA-C2负荷增加对KIR AA患者的活产率有负面影响。
- 选择HLA-C1而非HLA-C2供者可能对KIR AA患者的活产率有积极影响。
研究设计与样本
- 前瞻性观察性队列研究,纳入204例反复流产或反复种植失败女性。
- 分析所有女性及其伴侣、配子供者、流产组织和婴儿的KIR与HLA-C基因型。
- 按KIR、卵母细胞来源及单胚胎移植/双胚胎移植对临床变量进行分类分析。
主要发现
- 双胚胎移植后流产率:KIR AA母亲卵母细胞捐赠47.8%、体外受精37.5%;KIR AB卵母细胞捐赠10.5%、体外受精12.5%;KIR BB卵母细胞捐赠6.7%、体外受精0%。
- 卵母细胞捐赠双胚胎移植后活产率:KIR AA患者4.3%,KIR AB患者26.3%,KIR BB患者46.7%。
- KIR AA女性中,胎儿HLA-C2负荷增加时活产率显著降低。
关键数值与推荐
- KIR AA母亲双胚胎移植后流产率:卵母细胞捐赠47.8%,体外受精37.5%。
- KIR AB母亲双胚胎移植后流产率:卵母细胞捐赠10.5%,体外受精12.5%。
- KIR BB母亲双胚胎移植后流产率:卵母细胞捐赠6.7%,体外受精0%。
- 卵母细胞捐赠双胚胎移植后活产率:KIR AA 4.3%,KIR AB 26.3%,KIR BB 46.7%。
- 临床试验注册号:NCT04052438。
临床怎么用
- 作者认为选择性单胚胎移植较双胚胎移植改善生殖结局。
- 作者认为KIR AA患者选择HLA-C1而非HLA-C2供者可能对活产率有积极影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the pregnancy, miscarriages, and live birth rates (LBRs) according to maternal killer cell immunoglobulin-like receptor (KIR) genes expressed by uterine natural killer cells and paternal or oocyte donor human leukocyte antigen-C (HLA-C) genes expressed by trophoblast cells in patients with recurrent reproductive failure. DESIGN: Prospective observational cohort study. SETTING: Private infertility center. PATIENT(S): Participants included 204 women with recurrent miscarriage or recurrent implantation failure. INTERVENTION(S): The KIR and HLA-C genotypes of all women and HLA-C of their partners, gamete donors, miscarriage tissue, and babies were analyzed. MAIN OUTCOME MEASURE(S): All clinical variables (pregnancy, miscarriage, and LBRs) were analyzed and categorized based on KIR, oocyte origin, and single embryo transfer (SET)/double embryo transfer (DET). RESULT(S): A higher miscarriage rate was observed after DETs in KIR AA mothers (47.8% egg donation and 37.5% in vitro fertilization [IVF]) compared with KIR AB (10.5% egg donation and 12.5% IVF) or KIR BB (6.7% egg donation and 0% IVF). A significantly decreased LBR was observed after DETs with oocyte donation in KIR AA patients (4.3%) compared with KIR AB (26.3%) or BB (46.7%). The LBR decreased significantly as the fetal HLA-C2 load increased in KIR AA women. CONCLUSION(S): Elective SET improves the reproductive outcomes compared with DET. An increased embryo HLA-C2 load has a negative impact on the LBR in KIR AA patients. The selection of HLA-C1 over HLA-C2 donors could have a positive impact on the LBR in KIR AA patients. CLINICAL TRIAL REGISTRATION NUMBER: NCT04052438.
引用
- Alecsandru D, Barrio A, Garrido N, et al. Parental human leukocyte antigen-C allotypes are predictive of live birth rate and risk of poor placentation in assisted reproductive treatment. Fertil Steril. 2020. PMID: 32741616. doi:10.1016/j.fertnstert.2020.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。